(2 weeks, 4 days ago)
Commons ChamberI recently met pharmacists in my constituency, who expressed concern about the resilience of the supply chain, and specifically about wholesale suppliers spreading rumours, with the result that medicines are stockpiled, forcing up prices. In this case, it was Ramipril, but this is an issue across the board. It is the British taxpayer—our constituents—who suffer. Is the Secretary of State aware of this issue, and has she considered getting the Competition and Markets Authority involved?